All lobbying filings

THE MCMANUS GROUP

THE MCMANUS GROUP filed a Q2 report for VIALASE INC. on July 20, 2026, reporting $50,000 in lobbying income.

Lobbying for VIALASE INC. · Ophthalmic Medical Device Company

All filings by THE MCMANUS GROUP · Everything VIALASE INC. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Education on ophthalmic medical devices.

Medicare/Medicaid

Patient access and reimbursement of ophthalmic medical devices.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.